Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ESTA NASDAQ:EYE NASDAQ:NVCR NASDAQ:TCMD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeESTAEstablishment Labs$65.76$64.56$33.35▼$83.31$1.94B1.12536,084 shs532,859 shsEYENational Vision$17.45$24.84$14.75▼$30.02$1.40B1.182.48 million shs3.71 million shsNVCRNovoCure$17.58$12.92$9.82▼$20.06$2.04B0.91.91 million shs1.41 million shsTCMDTactile Systems Technology$22.74$25.49$9.34▼$37.77$513.01M0.82400,017 shs331,464 shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceESTAEstablishment Labs0.00%-8.37%-1.97%-11.85%+81.86%EYENational Vision0.00%-24.00%-32.05%-38.16%-9.21%NVCRNovoCure0.00%-1.73%+37.02%+59.96%-1.73%TCMDTactile Systems Technology0.00%-11.35%-11.62%-14.03%+118.65%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeESTAEstablishment Labs$65.76$64.56$33.35▼$83.31$1.94B1.12536,084 shs532,859 shsEYENational Vision$17.45$24.84$14.75▼$30.02$1.40B1.182.48 million shs3.71 million shsNVCRNovoCure$17.58$12.92$9.82▼$20.06$2.04B0.91.91 million shs1.41 million shsTCMDTactile Systems Technology$22.74$25.49$9.34▼$37.77$513.01M0.82400,017 shs331,464 shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceESTAEstablishment Labs0.00%-8.37%-1.97%-11.85%+81.86%EYENational Vision0.00%-24.00%-32.05%-38.16%-9.21%NVCRNovoCure0.00%-1.73%+37.02%+59.96%-1.73%TCMDTactile Systems Technology0.00%-11.35%-11.62%-14.03%+118.65%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceESTAEstablishment Labs 2.63Moderate Buy$87.1432.52% UpsideEYENational Vision 2.54Moderate Buy$29.2367.51% UpsideNVCRNovoCure 2.38Hold$27.2955.21% UpsideTCMDTactile Systems Technology 2.86Moderate Buy$38.6069.74% UpsideCurrent Analyst Ratings BreakdownLatest TCMD, NVCR, ESTA, and EYE Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/15/2026EYENational Vision CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$40.00 ➝ $39.005/14/2026EYENational Vision Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold (C-) ➝ Hold (C)5/14/2026EYENational Vision Roth MkmSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$25.005/14/2026EYENational Vision UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$42.00 ➝ $36.005/14/2026EYENational Vision Morgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetEqual Weight$30.00 ➝ $22.005/14/2026EYENational Vision BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOverweight$38.00 ➝ $27.005/14/2026EYENational Vision Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetEqual Weight$30.00 ➝ $20.005/14/2026EYENational Vision Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$35.00 ➝ $30.005/7/2026ESTAEstablishment Labs BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$88.00 ➝ $90.005/7/2026TCMDTactile Systems Technology B. Riley FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeNeutral ➝ Buy$32.00 ➝ $36.005/6/2026TCMDTactile Systems Technology Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C+) ➝ Hold (C-)(Data available from 5/18/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookESTAEstablishment Labs$211.08M9.17N/AN/A$0.81 per share81.19EYENational Vision$1.99B0.70$1.79 per share9.75$10.96 per share1.59NVCRNovoCure$655.35M3.11N/AN/A$3.04 per share5.78TCMDTactile Systems Technology$329.52M1.56$1.15 per share19.74$9.80 per share2.32Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateESTAEstablishment Labs-$51.06M-$1.49N/A469.71N/A-19.05%-218.77%-12.31%8/6/2026 (Estimated)EYENational Vision$29.60M$0.5730.6118.561.342.31%6.41%2.81%8/5/2026 (Estimated)NVCRNovoCure-$136.23M-$1.53N/AN/AN/A-25.66%-50.82%-16.48%7/23/2026 (Estimated)TCMDTactile Systems Technology$19.09M$0.8825.8415.68N/A5.91%9.70%7.53%8/3/2026 (Estimated)Latest TCMD, NVCR, ESTA, and EYE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2026Q1 2026EYENational Vision$0.43$0.45+$0.02$0.38$545.09 million$543.88 million5/7/2026Q1 2026ESTAEstablishment Labs-$0.3550-$0.45-$0.0951-$0.45$57.40 million$59.88 million5/4/2026Q1 2026TCMDTactile Systems Technology-$0.07-$0.08-$0.01-$0.08$70.57 million$75.27 million4/30/2026Q1 2026NVCRNovoCure-$0.5122-$0.62-$0.1078-$0.62$167.77 million$174.06 million3/4/2026Q4 2025EYENational Vision$0.06$0.15+$0.09$0.04$495.26 million$503.41 million2/26/2026Q4 2025NVCRNovoCure-$0.41-$0.22+$0.19-$0.22$174.40 million$174.35 million2/24/2026Q4 2025ESTAEstablishment Labs-$0.22-$0.09+$0.13-$0.09$63.80 million$64.62 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthESTAEstablishment LabsN/AN/AN/AN/AN/AEYENational VisionN/AN/AN/AN/AN/ANVCRNovoCureN/AN/AN/AN/AN/ATCMDTactile Systems TechnologyN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioESTAEstablishment Labs16.822.961.91EYENational Vision0.250.620.37NVCRNovoCure0.712.902.70TCMDTactile Systems TechnologyN/A4.243.78Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipESTAEstablishment Labs72.91%EYENational VisionN/ANVCRNovoCure84.61%TCMDTactile Systems Technology83.43%Insider OwnershipCompanyInsider OwnershipESTAEstablishment Labs9.99%EYENational Vision2.40%NVCRNovoCure5.52%TCMDTactile Systems Technology2.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableESTAEstablishment Labs1,00429.43 million26.49 millionOptionableEYENational Vision13,13880.12 million78.19 millionOptionableNVCRNovoCure1,605115.82 million109.43 millionOptionableTCMDTactile Systems Technology1,08622.56 million22.08 millionOptionableTCMD, NVCR, ESTA, and EYE HeadlinesRecent News About These CompaniesVanguard Group Inc. Boosts Position in Tactile Systems Technology, Inc. $TCMDMay 17 at 6:50 AM | marketbeat.comElaine Birkemeyer Sells 4,631 Shares of Tactile Systems Technology (NASDAQ:TCMD) StockMay 14, 2026 | insidertrades.com52,740 Shares in Tactile Systems Technology, Inc. $TCMD Bought by RFG Advisory LLCMay 9, 2026 | marketbeat.comB Riley Securities upgrades Tactile Systems Technology (TCMD)May 8, 2026 | msn.comTactile Systems Technology, Inc. (NASDAQ:TCMD) Receives Consensus Recommendation of "Moderate Buy" from AnalystsMay 8, 2026 | americanbankingnews.comTactile Systems Technology, Inc. (NASDAQ:TCMD) Receives Consensus Rating of "Moderate Buy" from AnalystsMay 8, 2026 | marketbeat.comTactile Systems Technology, Inc. (NASDAQ:TCMD) Just Released Its First-Quarter Earnings: Here's What Analysts ThinkMay 7, 2026 | finance.yahoo.comTactile Systems Technology (NASDAQ:TCMD) Upgraded by B. Riley Financial to Buy RatingMay 7, 2026 | marketbeat.comHealthcare Momentum Drives Interest In Tactile Systems Technology (NASDAQ:TCMD)May 6, 2026 | kalkinemedia.comKBTIG Keeps Their Buy Rating on Tactile Systems Technology (TCMD)May 6, 2026 | theglobeandmail.comPiper Sandler Sticks to Its Buy Rating for Tactile Systems Technology (TCMD)May 6, 2026 | theglobeandmail.comShould Value Investors Buy Tactile Systems Technology (TCMD) Stock?May 6, 2026 | zacks.comTactile Medical projects $360M-$368M 2026 revenue as Medicare prior authorization process maturesMay 5, 2026 | msn.comTactile Systems (TCMD) Q1 2026 Earnings TranscriptMay 5, 2026 | finance.yahoo.comBTIG Research Issues Positive Forecast for Tactile Systems Technology (NASDAQ:TCMD) Stock PriceMay 5, 2026 | marketbeat.comTactile Systems Technology, Inc. (TCMD) Q1 2026 Earnings Call TranscriptMay 4, 2026 | seekingalpha.comTactile Systems Technology Q1 Earnings Call HighlightsMay 4, 2026 | marketbeat.comTactile Systems Technology (TCMD) Reports Q1 Loss, Tops Revenue EstimatesMay 4, 2026 | zacks.comTactile Systems Technology (NASDAQ:TCMD) Announces Quarterly Earnings Results, Misses Expectations By $0.01 EPSMay 4, 2026 | marketbeat.comTactile Systems Technology, Inc. Reports First Quarter 2026 Financial ResultsMay 4, 2026 | globenewswire.comTactile Systems Technology (TCMD) Expected to Announce Quarterly Earnings on MondayApril 27, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesThe $880M Bet to Survive Real Estate's ResetBy Jeffrey Neal Johnson | April 28, 2026Did Qualcomm Just Put Apple in Check?By Jeffrey Neal Johnson | April 28, 2026Prologis Q1 2026: Data Centers Steal the ShowBy Chris Markoch | April 18, 2026Does Cheesecake Factory Stock Have Any Upside Left on the Menu?By Jennifer Ryan Woods | April 27, 2026Freeport-McMoRan: Grasberg Restarts, Now the Real Work BeginsBy Chris Markoch | April 24, 2026TCMD, NVCR, ESTA, and EYE Company DescriptionsEstablishment Labs NASDAQ:ESTA$65.76 0.00 (0.00%) Closing price 05/15/2026 04:00 PM EasternExtended Trading$65.77 +0.01 (+0.02%) As of 06:17 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.National Vision NASDAQ:EYE$17.45 0.00 (0.00%) Closing price 05/15/2026 04:00 PM EasternExtended Trading$17.71 +0.26 (+1.48%) As of 07:10 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.NovoCure NASDAQ:NVCR$17.58 0.00 (0.00%) Closing price 05/15/2026 04:00 PM EasternExtended Trading$17.47 -0.11 (-0.61%) As of 07:07 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.Tactile Systems Technology NASDAQ:TCMD$22.74 0.00 (0.00%) Closing price 05/15/2026 04:00 PM EasternExtended Trading$23.00 +0.26 (+1.16%) As of 05/15/2026 06:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Peloton Stock Gives Back Gains After Upbeat Earnings Report MarketBeat Week in Review – 05/11 - 05/15 Datavalut Gains Traction: 5 Reasons to Sell Now TMC Stock: Why This Pre-Revenue Miner Is Worth Watching Alphabet's Googlebook Brings Gemini AI to PC Hardware As Broadcom Eclipses $2 Trillion, Private Credit Giants Wants In Robinhood, SoFi, and Webull Are Telling Very Different Stories Viking Sails to All-Time Highs—Fundamentals Signal More to Come Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
